1. Home
  2. RITM vs APGE Comparison

RITM vs APGE Comparison

Compare RITM & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rithm Capital Corp.

RITM

Rithm Capital Corp.

HOLD

Current Price

$5.08

Market Cap

5.2B

Sector

Real Estate

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

N/A

Current Price

$134.75

Market Cap

4.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RITM
APGE
Founded
2011
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.7B
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
RITM
APGE
Price
$5.08
$134.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
13
Target Price
$14.06
$109.67
AVG Volume (30 Days)
5.5M
1.2M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
10.35%
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$4,590,228,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$28.68
N/A
P/E Ratio
$64.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.43
$35.39
52 Week High
$12.74
$134.88

Technical Indicators

Market Signals
Indicator
RITM
APGE
Relative Strength Index (RSI) 58.62 77.42
Support Level $8.98 $134.03
Resistance Level $10.27 $134.88
Average True Range (ATR) 0.20 0.20
MACD -0.00 -0.75
Stochastic Oscillator 53.96 87.65

Price Performance

Historical Comparison
RITM
APGE

About RITM Rithm Capital Corp.

Rithm Capital Corp operates as a real estate investment trust that provides capital and services to the real estate and financial services industries. The company aims to generate attractive risk-adjusted returns in all interest-rate environments through a complementary portfolio of investments and operating businesses. Its investment portfolio is composed of mortgage servicing-related assets (full and excess MSRs and servicer advances), residential securities (and associated call rights), loans (including single-family rental), and consumer loans. Its operating segments are Origination and Servicing; Investment Portfolio; Residential Transitional Lending; and Asset Management.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: